Search clinical trials for: Mood

Total 7256 results

Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study of the Effects of Paroxetine on the Pharmacokinetics of Paliperidone ER

Schizophrenia
Johnson & Johnson Pharmaceutical Research & Development...
Janssen, LP

Completed

A Study of Effectiveness and Safety of Risperdal CONSTA Added to Usual Treatment in Patients With Bipolar Disorder Who Have Frequent Mood Episodes.

Bipolar Disorder
Johnson & Johnson Pharmaceutical Research & Development...
Janssen, LP

Completed

A Study of the Effectiveness and Safety of Risperidone to Augment SSRI Therapy in Patients With Treatment-resistant Depression

Depressive Disorder | Depression | Depressive Disorder, Major
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study of QT and QTc Intervals in Patients Administered Extended Release Paliperidone or Quetiapine

Schizophrenia | Schizoaffective Disorder
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Pharmacokinetic Study of the Relative Bioavailability of Paliperidone ER Formulations With Different Release Profiles and a Comparison to Paliperidone IR

Schizophrenia
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study of the Effect of Carbamazepine on the Pharmacokinetics of Paliperidone Extended Release (ER) in Patients With Schizophrenia or Bipolar I Disorder

Schizophrenia | Bipolar Disorder
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study of the Dose Proportionality of Extended Release Paliperidone

Schizophrenia
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study of the Effect of Food and Posture on the Pharmacokinetics of a Single Dose of ER OROS Paliperidone

Schizophrenia
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study of the Bioequivalence of 12 mg Paliperidone Extended Release Tablets Manufactured at Gurabo and Vacaville

Schizophrenia
Janssen-Ortho Inc., Canada

Completed

CONCERTA® (Methylphenidate Hydrochloride) as add-on Therapy in the Treatment of Adult Major Depressive Disorder.

Depressive Disorder, Major
Public Research Centre Health, Luxembourg
Fonds National de la Recherche Scientifique; Université de Liège; Hôpital du... and other collaborators

Unknown

Mental Health Related to School Dropout in Luxembourg

Psychotic Disorders | Mood Disorders | Anxiety Disorders | Antisocial Personality Disorder | Eating Disorders | Substance-related Disorders | Impulse Control Disorders

Luxembourg
Herlev Hospital

Completed

The Use of Major Depression Inventory (MDI) in Measuring Preoperative Depressive Symptoms in Breast Cancer Patients

Depression | Depressive Symptoms

Denmark
AstraZeneca

Completed

Study Comparing the Tolerability of Seroquel IR With Seroquel XR in Patients With Bipolar Depression

Bipolar Depression
Tel-Aviv Sourasky Medical Center

Completed

Treatment of Postpartum Depression With Psychotherapy and Add-on Sertraline

Postpartum Depression

Israel
Wyeth is now a wholly owned subsidiary of Pfizer
Pfizer

Completed

Study Evaluating Desvenlafaxine Succinate Sustained Release In Adults With Major Depressive Disorder

Major Depressive Disorder

United States
Bristol-Myers Squibb

Terminated

A Comparison of Atazanavir and Nelfinavir, Each in Combination With 2 NRTIs, in Patients Who Have Failed Treatments Without a Protease Inhibitor

HIV Infections

United States, Mexico, Canada, Puerto Rico, Thailand
PharmaNeuroBoost N.V.

Completed

Pipamperone/Citalopram (PipCit)Versus Citalopram in the Treatment of Major Depressive Disorder(MDD)

Depression

United Kingdom
University of North Carolina, Chapel Hill
Eli Lilly and Company

Completed

Study of Amantadine for Weight Stabilization During Olanzapine Treatment

Schizophrenia | Schizoaffective Disorder | Schizophreniform Disorder | Psychotic Disorder | Mood Disorders With Psychotic Features

United States
The University of New South Wales

Completed

A Study of Transcranial Direct Current Stimulation (tDCS) to Treat Depression

Bipolar Disorder | Depressive Disorder, Major

Australia
University of Virginia
American Association of Chairs of Departments of Psychiatry

Withdrawn

Dose Response of Mirtazapine to Methamphetamine Induced Interest, Mood Elevation and Reward

Amphetamine Dependence

United States
Pfizer

Completed

Long-Term Safety Of DVS-233 SR In Patients With Major Depressive Disorder

Major Depressive Disorder

United States, Germany, Estonia, Finland, Former Serbia and Montenegro, France, Latvia, Lithuania, Poland, Slovakia, South Africa
Technical University of Munich

Completed

Effect of Quetiapine XR on Sleep in Patients With Major Depression, as Compared With Mirtazapine

Sleep

Germany
Sanofi

Completed

A Trial Evaluating the Efficacy and Tolerability of SSR125543 in Outpatients With Major Depressive Disorder (AGATE)

Major Depression

Belgium, Canada, Chile, Estonia, Finland, France, Germany, Netherlands, Russian Federation, Slovakia, South Africa, Sweden
University of Illinois at Chicago
National Institute of Mental Health (NIMH)

Unknown

Depression in Type 2 Diabetes

Depression | Diabetes Mellitus

United States
University of Illinois at Chicago
National Institute of Mental Health (NIMH)

Unknown

Late-Life Depression

Depression

United States
GlaxoSmithKline

Completed

Effects Of Antidepressants On Sexual Functioning In Adults

Major Depressive Disorder (MDD)

United States
Dr. D McIntosh & Dr. K Kjernisted Clinical Research...
AstraZeneca

Unknown

Measuring Response to Depression Treatment

Depression

Canada
Icahn School of Medicine at Mount Sinai
National Institute on Minority Health and Health Disparities (NIMHD)

Completed

Mothers Avoiding Depression Through Empowerment Intervention Trial (MADE IT)

Postpartum Depression

United States
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Desvenlafaxine Succinate Sustained Release In Outpatients With Major Depressive Disorder

Depressive Disorder, Major
United States Department of Defense
GlaxoSmithKline

Unknown

Effects of Omega-3 EPA/DHA for Soldiers at Risk for Mood Disorders

Depression | Mood Disorders | Combat Disorders | Stress Disorders

Iraq
Catalysis SL

Completed

Deprexil in Subjects With Signs and Symptoms of Depression

Depression

Cuba
University of Nottingham
Burdett Trust for Nursing; Nottinghamshire Healthcare NHS Trust; Nottingham City... and other collaborators

Completed

Promoting Wellbeing for Women With Depression: A Pragmatic Randomised Controlled Trial (RCT) of an Exercise Programme

Depression

United Kingdom
China Medical University, China

Completed

Efficacy of Olanzapine Monotherapy for Treatment Bipolar Ⅰ Depression

Bipolar Disorder | Depression, Bipolar

China
Institute of Neuroscience, Florence, Italy

Completed

Bilateral Versus Monolateral Repetitive Transcranial Stimulation in Depression

Major Depression

Italy
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Desvenlafaxine Succinate Sustained-Release (DVS SR) In The Treatment Of Child And Adolescent Outpatients With Major Depressive Disorder

Depression | Major Depressive Disorder

United States
University of Pittsburgh

Unknown

Primary Prevention of Major Depression in Later Life

Depression

United States
Ospedale Amedeo di Savoia

Unknown

Italian Network for the Improvement of Compliance in Depression

Depression

Italy
Zhejiang University

Unknown

Depression Care Management for Depressed Elders in China Primary Care (DCM)

Depression

China
AstraZeneca

Completed

Safety and Efficacy Trial of the Use of Quetiapine Fumarate (SEROQUEL®) in the Treatment of Patients With Bipolar Depression

Bipolar Disorder | Depression, Bipolar

United States
AstraZeneca

Completed

Efficacy of Seroquel SR in Combination With an Antidepressant in Treatment of Major Depressive Disorder (ONYX)

Major Depressive Disorder

Sweden, Czech Republic, France, Germany, Poland, Romania, Finland, Norway, Belgium, Canada, Australia, South Africa
Pfizer

Completed

Retrospective Study Evaluating The Current Utilization Of Desvenlafaxine Succinate Sustained-Release (Pristiq) Among Psychiatrists And Primary Care Physicians In The Treatment Of Patients With Major Depressive Disorder

Major Depressive Disorder
Sunnybrook Health Sciences Centre

Completed

Risperidone vs. Olanzapine as add-on Treatment in Treatment Resistant Depression

Subjects Had Unipolar, Non-psychotic Major Depression

Canada
Janssen Korea, Ltd., Korea

Completed

The Safety and Efficacy of Risperidone as Adjunctive Therapy to Mood Stabilizers in the Long-term Treatment of Bipolar Mania

Bipolar Disorder
Johnson & Johnson Pharmaceutical Research & Development...

Completed

A Study of the Effectiveness and Safety of Risperidone as add-on Therapy to Mood Stabilizers in the Treatment of Manic Episodes Associated With Bipolar Disorder

Bipolar Disorders | Manic Disorder
AstraZeneca

Completed

AZD6765 for Treatment Resistant Depression

Depression

United States
University of Ottawa

Completed

Treatment-Resistant Depression, Hippocampus Atrophy and Serotonin Genetic Polymorphism

Major Depression

Canada
Repligen Corporation

Completed

A Study to Assess the Safety, Tolerability and Efficacy of RG2417 in Bipolar I Depression

Bipolar I Depression

United States
Mount Sinai Hospital, Canada

Completed

Safety and Antidepressant Effects of Rellidep in Major Depressive Disorder

Depression

Canada
Japan Liver Oncology Group

Unknown

Sonazoid Enhanced Liver Cancer Trial for Early Detection

Liver Cirrhosis | Hepatitis B | Hepatocellular Carcinoma | Hepatitis C

Japan
Fundació Institut de Recerca de l'Hospital de la...
Fondo de Investigacion Sanitaria

Unknown

DBS in Treatment Resistant Major Depression

Resistant Major Depressive Disorder

Spain

Search clinical trials for: Mood

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Madagascar

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations